Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Current Taxes (2016 - 2022)

Usana Health Sciences (USNA) has disclosed Current Taxes for 10 consecutive years, with $5.2 million as the latest value for Q1 2022.

  • On a quarterly basis, Current Taxes fell 58.48% to $5.2 million in Q1 2022 year-over-year; TTM through Jan 2022 was $5.2 million, a 58.48% decrease, with the full-year FY2022 number at $5.2 million, down 58.48% from a year prior.
  • Current Taxes was $5.2 million for Q1 2022 at Usana Health Sciences, down from $12.5 million in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $12.5 million in Q1 2021 to a low of $5.2 million in Q1 2022.
  • A 4-year average of $8.7 million and a median of $8.5 million in 2018 define the central range for Current Taxes.
  • Peak YoY movement for Current Taxes: soared 52.82% in 2019, then tumbled 58.48% in 2022.
  • Usana Health Sciences' Current Taxes stood at $6.7 million in 2018, then skyrocketed by 52.82% to $10.2 million in 2019, then grew by 22.03% to $12.5 million in 2021, then crashed by 58.48% to $5.2 million in 2022.
  • Per Business Quant, the three most recent readings for USNA's Current Taxes are $5.2 million (Q1 2022), $12.5 million (Q1 2021), and $10.2 million (Q4 2019).